Academic and independent researchers are slowly filling this void, but it takes time
As the market for GLP-1 drugs is predominantly concentrated in the U.S
Mller RH, Mder K, Gohla S
These data provide further support for the hypothesis that DPP-4 inhibitors may increase the risk of biliary tumors
In the research that exists, GHK-Cu has a reassuring safety profile: it occurs naturally in the body, is active at tiny (nanomolar) amounts, and has been used in topical cosmetics for decades without notable problems.[2] That track record, though, is mostly about topical use the safety of injected GHK-Cu has not been established in controlled human trials, and it's not an approved drug
Understanding how hormones and medications can impact conditions such as obesity, type 2 diabetes, and related health concerns is an important part of our approach to rehabilitation and long-term wellness